Navigation Links
Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
Date:2/27/2009

- Data presented today at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium -

MALVERN, Pa., Feb. 27 /PRNewswire/ -- Ascenta Therapeutics announced today positive preliminary results from its Phase II study of AT-101 in combination with docetaxel and prednisone (D/P) in men with docetaxel refractory, castrate resistant prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in Orlando, FL. AT-101, an oral, pan-Bcl-2 inhibitor currently in double-blinded, randomized Phase II clinical trials in both prostate cancer and non-small cell lung cancer, is the lead compound in Ascenta Therapeutics' portfolio of apoptosis-triggering small molecules.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090227/PH75873 )

"This is the first report of several we plan to present this year from a large and growing data set demonstrating the broad therapeutic potential of AT-101," said Mel Sorensen, MD, CEO of Ascenta Therapeutics. "The evidence of resistance reversal from this refractory population supplements the earlier clinical data demonstrating robust activity with the same regimen in docetaxel-naive patients."

Initial findings from the ongoing open-label, multi-center study demonstrates that AT-101 can be administered safely with D/P in these patients. Investigators also observed clinical responses, based on both PSA and RECIST criteria, including four patients with a confirmed PR (partial response, defined as a PSA decline of 50 percent or greater).

"This first look at the data is very encouraging, particularly since all of these patients were truly refractory to docetaxel, having not simply failed to respond but actually experienced disease progression during prior therapy," said James Reeves, MD, principal investigator, Florida Cance
'/>"/>

SOURCE Ascenta Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
2. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
3. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
4. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
5. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
6. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
7. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
11. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  Cochlear Corporation ... decided to leave Cochlear to join Valencia Technologies ... friend, Jeff Greiner , who is the ... of Market Development and will be responsible for ... Valencia,s coin-sized neuromodulation device ...
(Date:3/30/2015)... , March 30, 2015  New York College of ... class Intellectual Properties portfolio with U.S. Patent #8,996,098 donated ... This patent represents a surgical instrument that allows surgeons ... if it were in the traditional format of a ... against medical databases during surgery, thus providing the surgeon ...
(Date:3/30/2015)... International Inc. (OTCQB: NUIN) ("Nutrastar" or the "Company"), a ... including commercially cultivated Cordyceps Militaris ("Cordyceps"), functional health beverages ... for the full year ended December 31, 2014. ... December 31, 2014   , Net ... in full year 2013. , Gross ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9
(Date:3/31/2015)... (PRWEB) March 31, 2015 Homeowners and ... Drivable Grass in action and installed in ... finished installation of a display plot of Drivable Grass ... , Drivable Grass is a permeable concrete pavement system ... to asphalt and concrete pavement, Drivable Grass qualifies for ...
(Date:3/31/2015)... A new study by Health eCareers found ... employee turnover as their greatest staffing concern this year and ... battle – once you have them, you need to keep ... trends in healthcare recruiting blog series , which profiles the ... in hospitals has high numbers and results in high costs ...
(Date:3/31/2015)... 31, 2015 Telemedicine technology is ... specialists at Barnes-Jewish Hospital to patients at Memorial ... Illinois Healthcare (SIH) system. , “Previously, when an ... maternal-fetal medicine consultation, she had to travel two ... and then talk with a Barnes-Jewish specialist,” says ...
(Date:3/30/2015)... Software and Cybersecurity Risk Management ... Best Practices for Compliance, **Presented by FDAnews and ... http://www.fdanews.com/CybersecurityMDWorkshop , This workshop — chaired by ... specifically designed to provide attendees with industry best ... device software safety. , In fact, it's a ...
(Date:3/30/2015)... Garden City, NY (PRWEB) March 31, 2015 ... as a 2015 Professional Woman of the Year. ... leadership in business. As the largest, most-recognized networking organization ... industry and profession, the National Association of Professional Women ... members and over 200 Local Chapters. , “I take ...
Breaking Medicine News(10 mins):Health News:Super-Sod Recently Completed a Drivable Grass Permeable Paver Demo at their Jacksonville Store 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 2Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 3Health News:New Survey Finds Staff Turnover Top Concern for Healthcare Recruiters in 2015 4Health News:Access to Maternal-fetal Experts Expands into Rural Communities 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 3Health News:FDAnews Announces New Dates — Software and Cybersecurity Risk Management for Medical Devices Workshop, May 11-12, 2015 2Health News:FDAnews Announces New Dates — Software and Cybersecurity Risk Management for Medical Devices Workshop, May 11-12, 2015 3Health News:FDAnews Announces New Dates — Software and Cybersecurity Risk Management for Medical Devices Workshop, May 11-12, 2015 4Health News:National Association of Professional Women Announces Stacey Lynne Irey, Office Manager at Mid Jersey Endodontic Group, a 2015 Professional Woman of the Year 2
... toward oral chemotherapy agents offers cancer patients greater freedom and ... medications also poses more chances for patients to skip doses, ... way. An increasing number of cancer patients who receive chemotherapy ... pill bottle each day rather than the drip of an ...
... 28 APS Healthcare, a leading provider of ... Oregon Department of Human Services (DHS), Division of ... disease and medical care management programs. The integrated ... clients to access healthcare, minimize catastrophic health events ...
... FRANCISCO, May 28 Funding for poison control services ... Poison control services cost California $5.9 million but save ... emergency room visits each year. Not only do ... the toll-free number, but emergency room doctors and nurses ...
... A new statewide poll of registered voters ... bill to give the U.S. Food and Drug Administration (FDA) ... is expected to debate this issue next week, and Senators ... whether Congress will finally pass this life-saving legislation.(Logo: ...
... The Centre for Epidemiological Studies into Sexually-Transmitted Diseases and ... Spain in 2005 to look into the prevalence of ... objective was to monitor the rates of infection with ... as the prevalence of risky behaviour. , "The ...
... A new statewide poll of registered voters finds that ... give the U.S. Food and Drug Administration (FDA) the authority ... to debate this issue next week, and Senators Cochran and ... will finally pass this life-saving legislation.(Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ...
Cached Medicine News:Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 2Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 3Health News:Oregon Department of Human Services Selects APS Healthcare to Manage Expanded Statewide Medicaid Program 2Health News:Oregon Department of Human Services Selects APS Healthcare to Manage Expanded Statewide Medicaid Program 3Health News:California to Become Only State Without Poison Control Services 2Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 2Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 3Health News:Spanish prostitutes least likely to use condoms 2Health News:New Mississippi Poll: Voters Strongly Support FDA Regulation of Tobacco Products 2Health News:New Mississippi Poll: Voters Strongly Support FDA Regulation of Tobacco Products 3
... ease of use with high software ... image guided system for neurosurgery that ... needs. With a 50% usage rate ... than 500 physicians, VectorVision Cranial is ...
... Millennium™ microsurgical system delivers on the ... technology. For the latest advancement in ... Bausch & Lomb Surgical offers CONCENTRIX™ ... pump to provide both flow and ...
Eye Bank Specular Microscope. Specular microscope for easy examination of corneal slice extracted from a donor....
... Operating Microscope with excellent maneuverability. ... light weight maintaining high quality. ... oblique by simply changing the ... design has resulted in a ...
Medicine Products: